Arbutus Biopharma Corporation Common Stock (ABUS) is a publicly traded Healthcare sector company. As of August 24, 2026, ABUS trades at $5.19 with a market cap of $1.03B and a P/E ratio of 6.56. ABUS moved +0.38% today. Year to date, ABUS is +8.32%; over the trailing twelve months it is +45.53%. Its 52-week range spans $2.71 to $5.45. Rallies surfaces ABUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ABUS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.19 |
| Market Cap | $1.03B |
| P/E Ratio | 6.56 |
| EPS | $0.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.45 |
| 52-Week Low | $2.71 |
| Volume | 978.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $181.72M |
| Net Income | $153.05M |
| Gross Margin | 0.00% |
ABUS analyst coverage data. Average price target: $0.00.